Summary Eloxx Pharmaceuticals Ltd (Eloxx) is a clinical-stage biopharmaceutical company which focuses on the discovery, development and commercialization of drugs for the treatment of rare and ultra-rare diseases caused by Premature Termination Codon (PTC) nonsense mutations.Its lead pipeline candidate is EXL-02; a translation read-through inducing drug is used to treat genetic diseases.
Its read-through therapy helps to treat genetic diseases that are induced by nonsense mutations.Eloxx target mutation areas include cystic fibrosis, duchene muscular dystrophy, mucopolysaccharidosis Type I, cystinosis and rett syndrome.
The company caters its services to biotech and pharma companies and hospitals among others.It also has presence in Waltham, Massachusetts, the US.
Eloxx is headquartered in Rehovot, Israel.
Eloxx Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings.The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period.
The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope - Financial Deals - Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company’s operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements - The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy - The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
Trauma Fixation Devices - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Trauma Fixation Devices - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Trauma Fixation Devices pipeline products with comparative analysis of the...
Colitis Disease - Global Clinical Trials Review, H2, 2020 Summary clinical trial report, “Colitis Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Colitis Clinical trials scenario.This report provides top line data relating to the clinical trials on Colitis. Report...
The Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2014-2020 report provides an understanding and access to the cancer monoclonal antibody partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in cancer monoclonal antibody partnering deals Most active companies...
Hepatocyte Growth Factor - Pipeline Review, H2 2020 Summary According to the recently published report ’Hepatocyte Growth Factor - Pipeline Review, H2 2020’; Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) pipeline Target constitutes close to 15 molecules. Hepatocyte Growth...
“Ilaris- Drug Insight and Market Forecast – 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Ilaris in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2017–2030 is...
200 pages •
By The Business Research Company
• Nov 2020
Bi-Specific MAbS Global Market Report 2020-30: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global bi-specific mabs market. This report focuses on bi-specific mabs market which is experiencing strong growth. The report gives a guide to the...
Cytokines are molecular messengers that allow the cells of the immune system to communicate with one another, to generate a coordinated, robust, but self-limited response to a target antigen. There are two types of cytokines used to treat patients with cancer, namely, interferons (INFs) and interleukins (ILs). A third type, called hematopoietic...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.